AMANDA HAWORTH: Open Payments
NPI 1962027847 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 59 payments from 16 companies in 2025. Trend: 2023 $72 · 2024 $1,188 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $230 |
| ABBVIE INC. | 14 | $223 |
| Biogen, Inc. | 5 | $157 |
| Vanda Pharmaceuticals Inc. | 6 | $149 |
| Corium, LLC | 8 | $135 |
| Lundbeck LLC | 4 | $66 |
| E.R. Squibb & Sons, L.L.C. | 1 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
Products named: Auvelity, VRAYLAR, ZURZUVAE, FANAPT, Azstarys, REXULTI, COBENFY, Qelbree.
Industry payments across KS — which companies pay providers there.
